Award recordCONTRACT

ALEXION PHARMACEUTICALS INC

PIID 36F79726D0143· VA Staff Offices· NAC FEDERAL SUPPLY SCHEDULE (36F797)· 6505 · DRUGS AND BIOLOGICALS· FY2026· $0 net obligations· UEI DKCXLGANZAN3· MA

Description

PPR

Base award description: 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

First action · last action
2026-06-11 · 2026-07-13
Transactions
3
First transaction's obligation
$0
Base + all options value (sum of deltas)
$1,041,101,484
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
999
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2026-06-11 · this action $0 · running total $0Modification P00001 · 2026-06-17 · this action $0 · running total $0Modification P00002 · 2026-07-13 · this action $0 · running total $0
  • Base2026-06-11+$0= $0
  • Mod P000012026-06-17+$0= $0
  • Mod P000022026-07-13+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2026-06-11+$0$065 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-06-17+$0$0TPR
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-07-13+$0$0PPR

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DKCXLGANZAN3)

AwardOffice · PSC / listingNet obligationsFY
36E79726A0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24526N0739245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$104,650FY2026
36C26026F0055260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$1,255,805FY2026
36C26025F0093260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$626,866FY2025
36C26024F0096260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$522,487FY2024
36C26024F0071260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$187,948FY2024

Other recipients under 6505 from NAC FEDERAL SUPPLY SCHEDULE (36F797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36F79726D058EREVOLUTION MEDICINES, INC.NAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0172LUNDBECK LLCNAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0195MILESTONE PHARMACEUTICALS USA, INC.NAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0165RECKITT BENCKISER LLCNAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0118OMEROS CORPORATIONNAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36F79726D0143_3600 · retrieved 2026-09-26.